Reduced Aortic and Arteriolar Growth by Captopril in Normotensive and Renal Hypertensive Rats

  • Duo H. Wang
  • Russell L. Prewitt
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 308)

Abstract

The influence of angiotensin II (AII) on vascular structure has been widely studied. Much evidence from in vitro experiments indicate that AII stimulates DNA and protein synthesis in cardiovascular tissue and induces hypertrophy in rat and human vascular smooth muscle cells. In vivo experiments using converting enzyme inhibition in hypertensive rats have been confounded with pressure decreases which can also reduce vascular wall structure. This experiment was designed to evaluate the effect of the renin-angiotensin system on microvascular function and structure in normotension and renal hypertension, and to determine whether captopril alters cross-sectional area of the aortic and arteriolar wall. These are the first whole animal data to show effects on aortic and microvascular wall growth when the production of AII is blocked and the animals are still hypertensive.

Keywords

Hydrolysis Glycerin Adenosine Diarrhea Angiotensin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hashimoto H, Prewitt RL, and Efaw CW. Alterations in the microvasculature of one-kidney, one-clip hypertensive rats. Am J Physiol 253: H933 - H940, 1987.PubMedGoogle Scholar
  2. 2.
    Koletsky S, Pavlicko KM, Rivera-velez JM. Renin-angiotensin activity in hypertensive rats with a single ischemic kidney. Lab Invest 24: 41–44, 1971.PubMedGoogle Scholar
  3. 3.
    Asaad M, Antonaccio MJ. Vascular wall renin in spontaneously hypertensive rats. Hypertension 4: 487–493, 1982.PubMedGoogle Scholar
  4. 4.
    Mizuno K, Nakamaru M, Higashimori K, Inagami T. Local generation and release of angiotensin II in peripheral vascular tissue. Hypertension 11: 223–229, 1988.PubMedGoogle Scholar
  5. 5.
    Owens GK, Schwartz SM. Alterations in vascular smooth muscle mass in the spontaneously hypertensive rat. Circ Res 51: 280–289, 1982.PubMedGoogle Scholar
  6. 6.
    Lindop GM, Lever AF. Anatomy of the renin-angiotensin system in the normal and pathological kidney. Histopathology 10: 335–362, 1986.PubMedCrossRefGoogle Scholar
  7. 7.
    Fujita T, Sakaguchi H, Sibagaki M, Fukui T, Nomura M, Sekiguichi S. Functional and histological studies. Am J Med 63: 467–474, 1977.PubMedCrossRefGoogle Scholar
  8. 8.
    Pasternack A, Perheentupa J. Hypertensive angiopathy in familial chloride diarrhoea. Lancet 2: 1047–1049, 1966.PubMedCrossRefGoogle Scholar
  9. 9.
    Fernandez LA, Twickler J, Mead A. Neovascularization produced by angiotensin II. JLab Clin Med 105: 141–145, 1985.Google Scholar
  10. 10.
    Heagerty AM, O11erenshaw JD. The phosphoinositide signalling system and hypertension. J Hypertension 5: 515–524, 1987.CrossRefGoogle Scholar
  11. 11.
    Naftilan AJ, Pratt RE, Dzau VJ. Angiotensin II induction of c-fos, cmyc and platelet derived growth factor in vascular smooth muscle cells. Clin Res 36: 303A, 1988.Google Scholar
  12. 12.
    Re RN, Vizard DL, Brown J, Bryan SE. Angiotensin II receptors in chromatin fragments generated by micrococcal nuclease. Biochem Biophys Res Commun 119: 220–227, 1984.PubMedCrossRefGoogle Scholar
  13. 13.
    Antonaccio MJ, Kerwin L. Pre-and postjunctional inhibition of vascular sympathetic function by captopril in SHR. Hypertension 3 (supp I): 54–62, 1981.Google Scholar
  14. 14.
    Owen NE, Villereal ML. Lys-bradykinin stimulates Na+ influx and DNA synthesis in cultured human fibroblasts. Cell 32: 979–985, 1983.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1991

Authors and Affiliations

  • Duo H. Wang
    • 1
  • Russell L. Prewitt
    • 1
  1. 1.Department of PhysiologyEastern Virginia Medical SchoolNorfolkUSA

Personalised recommendations